Cited by 207Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration

de Paula, Rogerio B., da Silva, Alexandre A., Hall, John E.·2004·Hypertension

Abstract

This study examined the importance of aldosterone (ALDO) in mediating changes in renal function and increased mean arterial pressure (MAP) during the development of dietary-induced obesity in chronically instrumented dogs. Mean arterial pressure, heart rate (HR), and cardiac output (CO) were recorded 24 hours per day in lean dogs (n=7) before and after administration of an ALDO antagonist, eplerenone (EP) (10 mg/kg twice daily), for 10 days. After 10 days of EP treatment, the dogs (n=7) were given a supplement of cooked beef fat for 5 weeks while EP was continued. An untreated group (n=6) was fed a high fat diet for 5 weeks and used as control (C). In lean dogs, EP decreased MAP from 89±4 to 84±4 mm Hg and glomerular filtration rate from 67.4±6.8 to 53.2±4.9 mL/min while inducing a small negative Na + balance (−42±12 mEq). Plasma renin activity increased from 0.4±0.1 to 2.7±0.7 ng AI/mL per hour and plasma K + increased from 4.8±0.1 to 6.1±0.3 mEq/L. After 5 weeks of a high fat diet, body weight increased 45% to 53% in EP and C obese dogs. In C dogs, MAP increased by 16±3 mm Hg, compared with only 7±1 mm Hg in EPLE dogs. Compared with untreated dogs, the EP dogs had smaller increases in CO (18±4.6% versus 43±1.5%), HR (33±5% versus 60±3%), glomerular filtration rate (19±5% versus 38±6%), and cumulative Na + balance (138±35 mEq versus 472±110 mEq) after 5 weeks of a high fat diet. Thus, EP markedly attenuated glomerular hyperfiltration, sodium retention, and hypertension associated with chronic dietary-induced obesity. These observations indicate that ALDO plays an important role in the pathogenesis of obesity hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000105624.68174.00

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mineralocorticoid receptor blockade markedly attenuated glomerular hyperfiltration in obese dogs fed a high-fat diet.

    “We showed that MR blockade markedly attenuated glomerular hyperfiltration in obese dogs fed an HFD47.”
  • In dogs fed a high-fat diet to produce obesity, MR antagonism with eplerenone blunted sodium retention, glomerular hyperfiltration, and the development of hypertension by more than 50%.

    “In dogs fed an HFD to produce obesity, MR antagonism with eplerenone blunted sodium retention, glomerular hyperfiltration and the development of hypertension by >50%47.”
  • In obese dogs, MR antagonism markedly attenuated sodium retention, hypertension, and glomerular hyperfiltration.

    “In obese dogs, for example, MR antagonism markedly attenuated sodium retention, hypertension, and glomerular hyperfiltration51 (Figure 4).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT) Hypertension. 2002;40:612-618.
  2. Reisen E, Weir M, Falkner B. Hutchinson HG, Anzalone DA, Tuck ML. Lisinopril versus hydrochlorothiazide in obese hypertensive patients. Hypertension. 1997;30:140 -145.
  3. Hall JE. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994;23:381-394.
  4. Hall JE, Guyton AC, Farr BM. A single-injection technique for measuring glomerular filtration rate. Am J Physiol. 1977;232:F72-F76.

Cited by

Sorted by citations

Authors
de Paula, R. B., da Silva, A. A., & Hall, J. E.
Affiliations
  • From the Department of Physiology and Biophysics and Center of Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson.
  • University of Mississippi Medical Center (US)
Venue
Hypertension
Published
2004-01
Volume
43
Issue
1
Pages
41-47
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2097090923
Cited by
207
References
34
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 12 · 2014: 8 · 2013: 11 · 2012: 19
FWCI
6.53
Type
journal article
Language
en
Open access
closed
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (P01-HL-51971, P01HL051971)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
aldosterone, eplerenone, obesity-related hypertension, glomerular hyperfiltration, diet-induced obesity, high-fat diet, sodium retention, plasma renin activity, plasma potassium, cardiac output, heart rate, renal function, mineralocorticoid receptor antagonists
MeSH terms
Eplerenone, Mineralocorticoid Receptor Antagonists, Animals, Dogs, Glomerular Filtration Rate, Hemodynamics, Hormones, Hypertension, Obesity, Sodium, Spironolactone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review